It was demonstrated that MYC expression was strongly increased by platinum treatment both in vitro and in vivo, and in combination with standard of care chemotherapy, CUDC-907 treatment decreased tumor growth and synergistically increased survival in the SCLC mouse model [17]. The gene discussed is MYC; the disease is small cell lung carcinoma.